Liam Ratcliffe

at Upstream Bio Inc. (UPB), 2024-10-15
at Eliem Therapeutics Inc. (ELYM), 2024-06-28
at Disc Medicine Inc. (IRON), 2024-06-14
Director at Arvinas Inc. (ARVN), 2022-06-22
Director at Passage Bio Inc. (PASG), 2021-05-28
Director at Unum Therapeutics Inc. (UMRX), 2019-06-18
Director at Aptinyx Inc. (APTX), 2019-04-02
Director at Edge Therapeutics Inc. (EDGE), 2019-03-18
Large Shareholder at Iterum Therapeutics Plc (ITRM), 2018-05-31
Large Shareholder, Director at Deciphera Pharmaceuticals Inc. (DCPH), 2018-05-21
Large Shareholder at Irhythm Technologies Inc. (IRTC), 2016-10-25
Large Shareholder at Mei Pharma Inc. (MEIP), 2015-03-26
Large Shareholder at Versartis Inc. (VSAR), 2014-12-22
Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
Large Shareholder at Chimerix Inc (CMRX), 2014-03-20
Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
Other at Oxford Immunotec Global Plc (OXFD), 2013-12-03
Other at Relypsa Inc (RLYP), 2013-11-21
Director at Array Biopharma Inc (ARRY), 2013-10-25

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Arvinas Inc.	ARVN	$70.00	142,857	Director	822,857	2020-12-18	Filing
Passage Bio Inc.	PASG	$18.00	2,800	Director	2,800	2020-03-03	Filing
Passage Bio Inc.	PASG	$18.00	550,000	Director	2,616,630	2020-03-03	Filing
Passage Bio Inc.	PASG	$18.00	2,800	Director	2,800	2020-03-03	Filing
Arvinas Inc.	ARVN	$22.00	680,000	Director	680,000	2019-11-12	Filing

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Arvinas Inc.	ARVN	$68.97	37,206	Director	185,686	2021-12-16	Filing
Arvinas Inc.	ARVN	$69.66	48,499	Director	222,892	2021-12-16	Filing
Arvinas Inc.	ARVN	$65.74	5,695	Director	271,391	2021-12-15	Filing
Arvinas Inc.	ARVN	$66.50	67,549	Director	277,086	2021-12-15	Filing
Arvinas Inc.	ARVN	$67.46	40,292	Director	344,635	2021-12-15	Filing